pd 145065 has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashley, SW; Gloor, B; Lane, JS; Lewis, MP; Reber, HA; Todd, KE | 1 |
| Ryrfeldt, A; Svens, K | 1 |
2 other study(ies) available for pd 145065 and Acute Disease
| Article | Year |
|---|---|
An ETa/ETb endothelin antagonist ameliorates systemic inflammation in a murine model of acute hemorrhagic pancreatitis.
Topics: Acute Disease; Animals; Choline Deficiency; Endothelins; Ethionine; Female; Hemorrhage; Inflammation; Mice; Oligopeptides; Pancreatitis | 1997 |
A study of mechanisms underlying amitriptyline-induced acute lung function impairment.
Topics: Acute Disease; Adrenergic beta-Agonists; Amitriptyline; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Bronchoconstriction; Bronchodilator Agents; Calcium Channel Blockers; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Enzyme Inhibitors; In Vitro Techniques; Lung; Nitric Oxide Donors; Oligopeptides; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Vasoconstriction | 2001 |